Publications by authors named "Peter Seubert"

Claim this Profile
E
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson's Disease.
Eliezer Masliah, Edward Rockenstein, Anthony Adame, Michael Alford, Leslie Crews, Peter Seubert

Neuron· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.
Brian Spencer, Elvira Valera, Edward Rockenstein, Cassia Overk, Michael Mante, Peter Seubert

Acta Neuropathol Commun· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.
Dora Games, Elvira Valera, Brian Spencer, Edward Rockenstein, Michael Mante, Peter Seubert

J Neurosci· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity.
Alfred T Welzel, John E Maggio, Ganesh M Shankar, Donald E Walker, Beth L Ostaszewski, Peter Seubert

Biochemistry· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition.
Adrienne L Orr, Jesse E Hanson, Dong Li, Adam Klotz, Sarah Wright, Peter Seubert

Neuron· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
Wagner Zago, Sally Schroeter, Teresa Guido, Karen Khan, Peter Seubert

Alzheimers Dement· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.
Jonathan S Wall, Stephen J Kennel, Angela Williams, Tina Richey, Alan Stuckey, Peter Seubert

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.
Dora Games, Peter Seubert, Edward Rockenstein, Christina Patrick, Margarita Trejo

Am J Pathol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.
Frédérique Bard, Michael Fox, Stuart Friedrich, Peter Seubert, Dale Schenk

Exp Neurol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of anti-AA amyloid-specific monoclonal antibodies.
Jonathan S Wall, Stephen J Kennel, Tina Richey, Amy Allen, Alan Stuckey, Peter Seubert

Front Immunol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific.
Wagner Zago, Manuel Buttini, Thomas A Comery, Christopher Nishioka, Shyra J Gardai, Peter Seubert

J Neurosci· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease.
Eliezer Masliah, Edward Rockenstein, Michael Mante, Leslie Crews, Brian Spencer, Peter Seubert

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of animal models in advancing amyloid-beta immunotherapy to the clinic.
Dora Games, Peter Seubert

Alzheimers Res Ther· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer disease.
Guriqbal S Basi, Hadar Feinberg, Farshid Oshidari, John Anderson, Robin Barbour, Peter Seubert

J Biol Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta.
Kaoru Yamada, Chiori Yabuki, Peter Seubert, Dale Schenk, Yukiko Hori

J Neurosci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
Sally Schroeter, Karen Khan, Robin Barbour, Minhtam Doan, Ming Chen, Peter Seubert

J Neurosci· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.
Michael Pride, Peter Seubert, Michael Grundman, Michael Hagen, John Eldridge

Neurodegener Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cells are the major source of alpha-synuclein in blood.
Robin Barbour, Kristin Kling, John P Anderson, Kelly Banducci, Tracy Cole, Peter Seubert

Neurodegener Dis· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse.
Peter Seubert, Robin Barbour, Karen Khan, Ruth Motter, Pearl Tang

Neurodegener Dis· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Abeta peptide in whole blood.
J Randall Slemmon, Cory L Painter, Sashi Nadanaciva, Florentina Catana, Ashley Cook, Peter Seubert

J Chromatogr B Analyt Technol Biomed Life Sci· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.
Robert G Riekse, Ge Li, Eric C Petrie, James B Leverenz, Darcy Vavrek, Peter Seubert

J Alzheimers Dis· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
Marion S Buckwalter, Bronwen S Coleman, Manuel Buttini, Robin Barbour, Dale Schenk, Peter Seubert

J Neurosci· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abeta species removal after abeta42 immunization.
James A R Nicoll, Edward Barton, Delphine Boche, Jim W Neal, Isidro Ferrer, Peter Seubert

J Neuropathol Exp Neurol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice as models: transgenic approaches and Alzheimer's disease.
Dora Games, Manuel Buttini, Dione Kobayashi, Dale Schenk, Peter Seubert

J Alzheimers Dis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
Dale B Schenk, Peter Seubert, Michael Grundman, Ron Black

Neurodegener Dis· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis